Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.
about
Rofecoxib for osteoarthritisCoxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity
P2860
Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Comparison of low-dose rofecox ...... trials of six weeks duration.
@en
Comparison of low-dose rofecox ...... trials of six weeks duration.
@nl
type
label
Comparison of low-dose rofecox ...... trials of six weeks duration.
@en
Comparison of low-dose rofecox ...... trials of six weeks duration.
@nl
prefLabel
Comparison of low-dose rofecox ...... trials of six weeks duration.
@en
Comparison of low-dose rofecox ...... trials of six weeks duration.
@nl
P2093
P2860
P1476
Comparison of low-dose rofecox ...... trials of six weeks duration.
@en
P2093
B Sarembock
C A F Zerbini
D B Rodgers
P2860
P304
P356
10.1080/030097402320817059
P577
2002-01-01T00:00:00Z